Carleton Sage, PhD, DiscoveryAI Business Line Leader, leads and contributes to the development and application of AI/ML approaches to drug discovery in support of Eurofins’ line of SAS tools and in the support of Integrated Drug Discovery across many target classes. He has been developing and applying computational approaches to drug discovery for more than 25 years. Prior to joining Eurofins, Carleton was a founder and Vice President of Computational Sciences at Beacon Discovery where he was involved in hit discovery through lead optimisation for several integrated drug discovery projects focused on GPCRs. Over his career, Carleton has contributed to dozens of drug discovery campaigns which have put more than 10 compounds into human clinical trials, and have resulted in two compounds reaching the market, Belviq (2014) and Velsipity (2023).
Dr Sage holds a PhD in Biochemistry and Molecular Biology from the University of California, Santa Barbara, and completed a postdoctoral fellowship in X-Ray Crystallography from the University of California, San Francisco. Dr Sage is a co-author on more than 30 publications and patents.
Is the webinar free?
Yes – there is no charge to watch the webinar on-demand.
I’m busy. Can I watch it later?
The webinar will become available to watch on-demand shortly after the live webinar takes place.
How long will the webinar be?
This webinar will last for up to one hour.
What do I need to watch this webinar?
All you need is a computer with an internet connection. Be sure to use headphones if in an office environment.
Do I receive a certificate?
Yes, you will receive a certificate if you attend the webinar live. The certificate will be sent with your on-demand video link.
